Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Crazy About ICF International Inc (ICFI)

Page 1 of 2

Is ICF International Inc (NASDAQ:ICFI) a good investment?

In today’s marketplace, there are plenty of indicators shareholders can use to monitor their holdings. A pair of the most innovative are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best money managers can trounce the market by a healthy amount (see just how much).

ICF International Inc (NASDAQ:ICFI)

Equally as key, bullish insider trading activity is a second way to analyze the world of equities. As the old adage goes: there are a number of stimuli for a corporate insider to sell shares of his or her company, but only one, very simple reason why they would buy. Plenty of empirical studies have demonstrated the useful potential of this method if investors understand where to look (learn more here).

Thus, let’s discuss the latest info for ICF International Inc (NASDAQ:ICFI).

Hedge fund activity in ICF International Inc (NASDAQ:ICFI)

At Q2’s end, a total of 13 of the hedge funds we track held long positions in this stock, a change of 44% from the first quarter. With hedgies’ capital changing hands, there exists a select group of noteworthy hedge fund managers who were upping their holdings meaningfully.

When using filings from the hedgies we track, Sagard Capital Partners Management Corp, managed by Dan Friedberg, holds the biggest position in ICF International Inc (NASDAQ:ICFI). Sagard Capital Partners Management Corp has a $48.3 million position in the stock, comprising 17.1% of its 13F portfolio. Sitting at the No. 2 spot is Third Avenue Management, managed by Martin Whitman, which held a $45.9 million position; the fund has 0.9% of its 13F portfolio invested in the stock. Other hedge funds with similar optimism include Chuck Royce’s Royce & Associates, D. E. Shaw’s D E Shaw and Joel Greenblatt’s Gotham Asset Management.

As aggregate interest spiked, certain money managers were leading the bulls’ herd. Sagard Capital Partners Management Corp, managed by Dan Friedberg, initiated the biggest position in ICF International Inc (NASDAQ:ICFI). Sagard Capital Partners Management Corp had 48.3 million invested in the company at the end of the quarter. Martin Whitman’s Third Avenue Management also initiated a $45.9 million position during the quarter. The other funds with brand new ICFI positions are Chuck Royce’s Royce & Associates, D. E. Shaw’s D E Shaw, and Joel Greenblatt’s Gotham Asset Management.

How are insiders trading ICF International Inc (NASDAQ:ICFI)?

Bullish insider trading is best served when the primary stock in question has seen transactions within the past 180 days. Over the latest half-year time period, ICF International Inc (NASDAQ:ICFI) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to ICF International Inc (NASDAQ:ICFI). These stocks are Wageworks Inc (NYSE:WAGE), Exponent, Inc. (NASDAQ:EXPO), Navigant Consulting, Inc. (NYSE:NCI), Standard Parking Corporation (NASDAQ:STAN), and Resources Connection, Inc. (NASDAQ:RECN). This group of stocks are in the management services industry and their market caps resemble ICFI’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!